Keyphrases
Inflammatory Bowel Disease
100%
Confidence Interval
76%
COVID-19
70%
Crohn's Disease
54%
United States
47%
Ulcerative Colitis
46%
Non-small Cell Lung Cancer (NSCLC)
33%
People Living with HIV (PLHIV)
33%
Pancreatic Cancer
32%
Odds Ratio
31%
High Risk
30%
AIDS/HIV
30%
New York City
28%
Risk Factors
26%
Hazard Ratio
25%
Hepatitis C Virus
24%
Meta-analysis
24%
Mount Sinai
24%
Vedolizumab
23%
Lung Cancer
23%
Chemotherapy
23%
Pharmacogenetics
22%
Cocaine Use Disorder
21%
Human Immunodeficiency Virus Type 1 (HIV-1)
21%
Comorbidity
21%
Palliative Care
20%
Tumor
20%
CYP2C9
20%
Clinical Outcomes
19%
HIV Patients
19%
Pancreatic Ductal Adenocarcinoma
19%
CYP2C19
19%
Inflammation
18%
Pharmacogenomics
18%
Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
18%
Surveillance Epidemiology
18%
Induced Pluripotent Stem Cells (iPSCs)
18%
Older Patients
17%
Neuroendocrine Tumor
17%
Hispanic
16%
Hospitalization
16%
Overall Survival
16%
High-risk Human Papillomavirus (HR-HPV)
16%
Healthy Controls
16%
Genotype
15%
Cardiac Sarcoidosis
15%
Pancreatic Neuroendocrine Tumors (pNETs)
15%
Cytochrome P450 2D6 (CYP2D6)
15%
Clinical Trials
15%
Clinical Genetics
14%
Lung Cancer Screening
14%
High-grade Squamous Intraepithelial Lesion
14%
Anal Cancer
14%
Functional Magnetic Resonance Imaging
14%
Pharmacogenetic Testing
14%
Cocaine
14%
Incidence Rate
14%
Elderly Patients
14%
Systematic Meta-analysis
13%
Adverse Events
13%
Multi-ethnic
13%
Clinical Pharmacogenetics Implementation Consortium
13%
COVID-19 Pandemic
13%
Suicidal Behavior
13%
Clinical Characteristics
13%
Borderline Personality Disorder
12%
Older Adults
12%
Warfarin Dose
12%
Oncologists
12%
VKORC1
12%
Bipolar Disorder
12%
High-risk Individuals
12%
Clinically Significant
12%
Autism Spectrum Disorder
12%
Lung Cancer Risk
12%
Goals of Care Conversations
12%
Peanut
12%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
12%
Ashkenazi Jews
11%
Murine Model
11%
Early-stage Lung Cancer
11%
Infectious Diseases
11%
Hepatitis C Treatment
11%
Non-associated
11%
Asthma
11%
Hepatitis C
11%
Positron Emission Tomography
11%
African American
11%
Clinical Practice
11%
Clinical Remission
11%
Cancer Incidence
11%
Monotherapy
10%
Schizotypal Personality Disorder
10%
Suicide Attempt
10%
Methicillin-resistant Staphylococcus Aureus
10%
Stage I Lung Cancer
10%
Endoscopic Remission
10%
Small Intestinal Neuroendocrine Tumors
10%
Critically Ill Patients
10%
Peanut Allergy
10%
Medicine and Dentistry
Human Immunodeficiency Virus
78%
COVID-19
64%
Disease
64%
Lung Cancer
58%
Malignant Neoplasm
58%
Neoplasm
50%
Inflammatory Bowel Disease
44%
Crohn's Disease
40%
Non Small Cell Lung Cancer
38%
Ulcerative Colitis
37%
Infection
35%
Neuroendocrine Tumor
31%
Patient with Inflammatory Bowel Disease
28%
Pancreas Cancer
27%
Inflammatory Bowel Disease
27%
Hepatitis C Virus
27%
Hazard Ratio
25%
Odds Ratio
25%
Symptomatic Treatment
23%
Anal Cancer
22%
Diseases
22%
Prevalence
22%
Surgery
21%
Vedolizumab
20%
Cohort Analysis
20%
Clinical Trial
19%
Pancreas Adenocarcinoma
19%
Clinician
19%
Biopsy Technique
19%
Drug Therapy
19%
Transplantation
18%
Wart Virus
18%
Hepatitis C
18%
Meta-Analysis
17%
Fluorodeoxyglucose F 18
17%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Comorbidity
17%
Gastroenteropancreatic Neuroendocrine Tumor
17%
Diagnosis
16%
Biological Marker
16%
Tumor Necrosis Factor
15%
Cancer
15%
Cancer Screening
15%
Primary Health Care
14%
Cardiac Sarcoidosis
14%
Cancer Risk
14%
Polyethylene Terephthalate
14%
Adverse Event
13%
Health Care Cost
13%
Pancreas Islet Cell Tumor
13%
Chemotherapy
13%
Positron Emission Tomography
13%
Biological Product
13%
Cancer Incidence
12%
Surveillance, Epidemiology, and End Results
12%
Overall Survival
12%
Medicare
12%
Systematic Review
12%
Hepatocellular Carcinoma
12%
Lung
12%
Quality of Life
11%
Computer Assisted Tomography
11%
Prostate Cancer
11%
Magnetic Resonance Imaging
11%
Cytotechnology
11%
Elderly Patient
11%
Lung Cancer Screening
11%
Oncologist
10%
Pharmacogenetics
10%
Immigrant
10%
Fibrosis
10%
Medicine
9%
Metastatic Carcinoma
9%
Recurrent Disease
9%
Logistic Regression Analysis
9%
Hepatitis B
9%
Proportional Hazards Model
9%
Squamous Cell Carcinoma
9%
Breast Cancer
9%
Adjuvant Chemotherapy
9%
Electronic Health Record
9%
Endoscopic Ultrasound
9%
Radiation Therapy
8%
Advanced Cancer
8%
Dysplasia
8%
Asthma
8%
Precursor
8%
Allele
8%
Cardiac Muscle Cell
8%
Oncology
8%
Colonoscopy
8%
Chronic Obstructive Pulmonary Disease
8%
Hepatitis B Virus
8%
Fluorine-18
8%
Health Care
8%
Health System
8%
Intensive Care Unit
8%
Patient Referral
8%
Cancer Therapy
8%
Adenocarcinoma
8%